Tag Archives: Diabetes

Secretive 'rebate trap' keeps generic drugs for diabetes and other ills out of reach

This is a Kaiser Health News story. Lisa Crook was lucky. She saved $ 800 last year after her insurance company started covering a new, less expensive insulin called Basaglar that was virtually identical to the brand she had used for years. The list price for Lantus, a long-acting insulin made by Sanofi that she… Read More »

FDA advisory panel split over Sanofi-Lexicon diabetes drug

(Reuters) – An advisory panel to the U.S. Food and Drug Administration was divided over whether to recommend approval of a treatment for type 1 diabetes developed by Lexicon Pharmaceuticals Inc and France’s Sanofi SA. The panel on Thursday voted 8-8 when asked to assess the once-daily oral medicine, sotagliflozin, an add-on to insulin therapy.… Read More »